Get started
Author

Eugenio Arrigoni

Observed names: E ARRIGONI, E. Arrigoni, Eugenio ARRIGONI
ORCID: 0000-0003-2378-8243
Observed ORCID: 0000-0003-2378-8243
OpenAlex ID: A5040272591
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course
2019 · Lorenzo Cavagna, Ernesto Trallero-Araguás, et al. · Journal of Clinical Medicine · 239
PDF
Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicentre retrospective study
2019 · Andreina Manfredi, Giulia Cassone, et al. · Internal Medicine Journal · 137
PDF
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies
2022 · Lorenzo Cavagna, Federica Meloni, et al. · Clinical and Experimental Rheumatology · 43
PDF
Quantitative chest computed tomography is associated with two prediction models of mortality in interstitial lung disease related to systemic sclerosis
2016 · Alarico Ariani, Mario Silva, et al. · Rheumatology · 41
PDF
Overall mortality in combined pulmonary fibrosis and emphysema related to systemic sclerosis
2019 · Alarico Ariani, Mario Silva, et al. · RMD Open · 34
PDF
Longitudinal change during follow-up of systemic sclerosis: correlation between high-resolution computed tomography and pulmonary function tests
2020 · Aldo Carnevale, Mario Silva, et al. · Clinical Rheumatology · 32
PDF
Operator-independent quantitative chest computed tomography versus standard assessment of interstitial lung disease related to systemic sclerosis: A multi-centric study
2015 · Alarico Ariani, Mario Silva, et al. · Modern Rheumatology · 29
Long-Term Retention Rate of Tofacitinib in Rheumatoid Arthritis: An Italian Multicenter Retrospective Cohort Study
2023 · Marino Paroli, Andrea Becciolini, et al. · Medicina · 16
PDF
Influence of Safety Warnings on the Prescribing Attitude of JAK Inhibitors for Rheumatoid Arthritis in Italy
2024 · Marino Paroli, Andrea Becciolini, et al. · Journal of Clinical Medicine · 14
PDF
Efficacy and Drug Survival after Switching from Etanercept to the Biosimilar SB4: A Real-Life Long-Term Study
2022 · Simone Parisi, Andrea Becciolini, et al. · Journal of Clinical Medicine · 14
PDF
Adalimumab and ABP 501 in the Treatment of a Large Cohort of Patients with Inflammatory Arthritis: A Real Life Retrospective Analysis
2022 · Andrea Becciolini, Simone Parisi, et al. · Journal of Personalized Medicine · 12
PDF
Effectiveness and Predictors of Long-Term Treatment Response to Tofacitinib in Rheumatoid Arthritis Cohort: General Analysis and Focus on High-Cardiovascular-Risk Subgroup—A Multicenter Study
2024 · Marta Priora, Andrea Becciolini, et al. · Medicina · 9
PDF
Apremilast retention rate in clinical practice: observations from an Italian multi-center study
2022 · Alarico Ariani, Simone Parisi, et al. · Clinical Rheumatology · 8
Therapeutic Effects of Apremilast on Enthesitis and Dactylitis in Real Clinical Setting: An Italian Multicenter Study
2023 · Alberto Lo Gullo, Andrea Becciolini, et al. · Journal of Clinical Medicine · 7
PDF
Predictors of DAPSA Response in Psoriatic Arthritis Patients Treated with Apremilast in a Retrospective Observational Multi-Centric Study
2023 · Andrea Becciolini, Simone Parisi, et al. · Biomedicines · 6
PDF
Ixekizumab Retention Rate and Predictors of Treatment Persistence in Psoriatic Arthritis: Results of an Italian Multicenter Study
2025 · Camilla Mazzanti, Marino Paroli, et al. · Journal of Psoriasis and Psoriatic Arthritis · 4
Guselkumab effectiveness in real-world settings: observations from an Italian multicentre study
2025 · Andrea Becciolini, Antonio Marchesoni, et al. · Rheumatology Advances in Practice · 4
PDF
Multicenter observational study on the efficacy of selective Janus Kinase-1 inhibitor upatacitinib in rheumatoid arthritis
2024 · Alberto LO GULLO, Simone PARISI, et al. · Minerva Medica · 4
Filgotinib Effectiveness in Rheumatoid Arthritis: Observational Analysis of a Large Multicenter Cohort
2025 · Eleonora Celletti, Myriam Di Penta, et al. · Rheumatology and Therapy · 2
PDF
Comparative effectiveness of cycling versus swapping to IL-17 inhibitors after first TNF inhibitor failure in Psoriatic Arthritis: A real-world multicenter study
2025 · Alarico Ariani, Maddalena Larosa, et al. · BMC Rheumatology · 2
PDF
Real life use of prostacyclin analog (iloprost), a multi-centric survey data from the Scleroderma study group Emilia Romagna (Sclero-RER) and review of the literature.
2023 · Luca Magnani, Alarico Ariani, et al. · Acta bio-medica dell'Ateneo parmense/Acta biomedica · 2
PDF
Diagnosis and treatment of rheumatoid arthritis in the Emilia Romagna region: a prospective population-based study.
2017 · Olga Addimanda, Massimiliano Marino, et al. · PubMed · 2
OP0095 Comparison of Interstitial Lung Disease CT Indexes and Pulmonary Function Values in Sistemic Sclerosis Patients: A Multicenter Study
2014 · A. Ariani, E. Bravi, et al. · Annals of the Rheumatic Diseases · 2
Six months predictors of DAPSA Remission With Guselkumab in Psoriatic Arthritis in a Multicenter Real-World Study
2026 · Alessandro Conforti, Alarico Ariani, et al. · Scientific Reports · 1
PDF
Does Prior Exposure Affect Retention? A Real-World, Multicentre Assessment of IL-17 Inhibitor Cycling in Psoriatic Arthritis
2026 · Valentino Paci, Alarico Ariani, et al. · Rheumatology and Therapy · 1
PDF
Works count: 56
Citation count: 670
H-index: 11
I10-index: 11
Year
Topic
Type